Difference between revisions of "IGH-EPOR"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
 
(12 intermediate revisions by the same user not shown)
Line 1: Line 1:
 +
[[Category:Translocations in B-ALL]]
 +
[[Category:Translocations]]
 +
[[Category:IGH Translocations]]
 +
[[Category:Translocations Chromosome 14]]
 +
[[Category:Translocations Chromosome 19]]
 +
[[Category:Structural Changes Chromosome 14]]
 +
[[Category:Structural Changes Chromosome 19]]
 +
[[Category:Cryptic]]
 +
[[Category:Recently Added Pages]]
 +
 
__TOC__
 
__TOC__
 +
==Contributors==
 +
[[Member Directory|Scott Newman PhD]]
  
 
==Diseases==
 
==Diseases==
Line 14: Line 26:
 
#Insertion of EPOR into the immunoglobulin kappa chain (IGK)  
 
#Insertion of EPOR into the immunoglobulin kappa chain (IGK)  
 
# Reciprocal t(14;19)(q32;p13) rearrangement of IGH to EPOR
 
# Reciprocal t(14;19)(q32;p13) rearrangement of IGH to EPOR
# Intrachromosomal inversion of chromosome 19 that juxtaposes EPOR to the up-stream region of LAIR1 (leukocyte-associated immunoglobulin-
+
# Intrachromosomal inversion of chromosome 19 that juxtaposes EPOR to the up-stream region of LAIR1 (leukocyte-associated immunoglobulin-like receptor 1) at chromosome 19q13
like receptor 1) at chromosome 19q13
 
  
 
==Co-occurring Lesions==
 
==Co-occurring Lesions==
EPOR rearrangements are frequently found in conjunction with [[IKZF1]] deletions and [[PAX5]] deletions within the Ph-like subgroup of ALL <ref>Iacobucci I, Li Y, Roberts KG, Dobson SM, Kim JC, Payne-Turner D, Harvey RC, Valentine M, McCastlain K, Easton J, Yergeau D, Janke LJ, Shao Y, Chen IM, Rusch M, Zandi S, Kornblau SM, Konopleva M, Jabbour E, Paietta EM, Rowe JM, Pui CH, Gastier-Foster J, Gu Z, Reshmi S, Loh ML, Racevskis J, Tallman MS, Wiernik PH, Litzow MR, Willman CL, McPherson JD, Downing JR, Zhang J, Dick JE, Hunger SP, Mullighan CG.
+
EPOR rearrangements are frequently found in conjunction with [[IKZF1]] deletions and [[PAX5]] deletions within the Ph-like subgroup of ALL.
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.
 
Cancer Cell. 2016 Feb 8;29(2):186-200. [http://www.ncbi.nlm.nih.gov/pubmed/26859458 PMID:26859458]</ref>.
 
  
{{Reflist}}
+
==References==

Latest revision as of 06:11, 7 August 2016


Contributors

Scott Newman PhD

Diseases

B-ALL; probably specific to the Phildelphia-like subgroup

Rearrangement Variants

Iacobucci et al. (2016) identified four types of EPOR rearrangement in the Phildelphia-like subgroup of B-ALL[1]: :

  1. Insertion of the EPOR locus distal to the immunoglobulin heavy chain (IGH) locus enhancer
  2. Insertion of EPOR into the immunoglobulin kappa chain (IGK)
  3. Reciprocal t(14;19)(q32;p13) rearrangement of IGH to EPOR
  4. Intrachromosomal inversion of chromosome 19 that juxtaposes EPOR to the up-stream region of LAIR1 (leukocyte-associated immunoglobulin-like receptor 1) at chromosome 19q13

Co-occurring Lesions

EPOR rearrangements are frequently found in conjunction with IKZF1 deletions and PAX5 deletions within the Ph-like subgroup of ALL.

References

  1. Iacobucci I, Li Y, Roberts KG, Dobson SM, Kim JC, Payne-Turner D, Harvey RC, Valentine M, McCastlain K, Easton J, Yergeau D, Janke LJ, Shao Y, Chen IM, Rusch M, Zandi S, Kornblau SM, Konopleva M, Jabbour E, Paietta EM, Rowe JM, Pui CH, Gastier-Foster J, Gu Z, Reshmi S, Loh ML, Racevskis J, Tallman MS, Wiernik PH, Litzow MR, Willman CL, McPherson JD, Downing JR, Zhang J, Dick JE, Hunger SP, Mullighan CG. Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. Cancer Cell. 2016 Feb 8;29(2):186-200. PMID:26859458